“We adjusted for race”: now what? A systematic review of utilization and reporting of race in American Journal of Epidemiology and Epidemiology, 2020–2021

ME Swilley-Martinez, SA Coles, VE Miller… - Epidemiologic …, 2023 - academic.oup.com
Race is a social construct, commonly used in epidemiologic research to adjust for
confounding. However, adjustment of race may mask racial disparities thereby perpetuating …

A narrative review of the role of diet and lifestyle factors in the development and prevention of endometrial cancer

HK Yasin, AH Taylor, T Ayakannu - Cancers, 2021 - mdpi.com
Simple Summary The incidence and prevalence of endometrial cancer is increasing
globally. The main factors involved in this increase have been the way women live today …

Global epidemiology of epithelial ovarian cancer

PM Webb, SJ Jordan - Nature Reviews Clinical Oncology, 2024 - nature.com
Globally, ovarian cancer is the eighth most common cancer in women, accounting for an
estimated 3.7% of cases and 4.7% of cancer deaths in 2020. Until the early 2000s, age …

Research progress on the treatment of premature ovarian failure using mesenchymal stem cells: a literature review

J Wang, W Liu, D Yu, Z Yang, S Li… - Frontiers in Cell and …, 2021 - frontiersin.org
Premature ovarian failure (POF) has become one of the main causes of infertility in women
of childbearing age and the incidence of POF is increasing year by year, seriously affecting …

Menopausal hormone therapy and ovarian and endometrial cancers: Long-term follow-up of the Women's Health Initiative randomized trials

RT Chlebowski, AK Aragaki, K Pan, R Haque… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Menopausal hormone therapy's influence on ovarian and endometrial cancers
remains unsettled. Therefore, we assessed the long-term influence of conjugated equine …

Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium

JL Petrick, CE Joslin, CE Johnson, TF Camacho… - British Journal of …, 2023 - nature.com
Background Most studies examining post-menopausal menopausal hormone therapy (MHT)
use and ovarian cancer risk have focused on White women and few have included Black …

[HTML][HTML] British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024

E Moss, A Taylor, A Andreou, C Ang, R Arora… - European Journal of …, 2024 - Elsevier
Recommendations are graded as per the Royal College of Obstetricians and
Gynaecologists document, Clinical Governance Advice No. 1: Guidance for the …

Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study

A Fournier, M Cairat, G Severi, MJ Gunter… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Epidemiological studies have found that menopausal hormone therapy (MHT)
use is associated with an increased ovarian cancer risk. However, whether different MHT …

Effects of risk factors for ovarian cancer in women with and without endometriosis

MT Phung, A Muthukumar, B Trabert, PM Webb… - Fertility and sterility, 2022 - Elsevier
Objective To evaluate the associations between 10 well-established ovarian cancer risk
factors and risk of ovarian cancer among women with vs. without endometriosis. Design …

A framework for assessing interactions for risk stratification models: the example of ovarian cancer

MT Phung, AW Lee, K McLean… - JNCI: Journal of the …, 2023 - academic.oup.com
Generally, risk stratification models for cancer use effect estimates from risk/protective factor
analyses that have not assessed potential interactions between these exposures. We have …